sciclone pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : sciclone pharmaceuticals

SCLN 11.15

0.0%

Oct 20 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AurumRabosa who wrote (417)	2/16/2000 3:47:00 PM
From: 5handicap	Read Replies (2) of 1137

TheStreet.com has come out with their list of biotechs. Maybe they should call it their list of the most overpriced biotechs. Take a look and compare to Sciclone, ticker.. P/S .. Mkt Cap (Billion$) AMGN...21. 66.5 IMNX...51.. 25.6 MEDI...31.. 10.8 CRA....288 .. 6.9 MLNM...44 .. 8.0 ABGX...450 .. 4.7 ALKS... 78 .. 3.0 CRGN... 167 .. 2.8 VRTX... 30 .. 1.35 IMCL...1000 .. 2.2 DNA.... 30 .. 43 BGEN... 20 .. 15.1 AFFX... 67 .. 6.8 HGSI... 290 .. 7.0 INCY... 35 .. 5.6 INHL... 41 .. 1.4 IDPH... 50 .. 4.9 GENZ... 7 .. 4.4 PDLI... 95 .. 3.2 TKTX... 220 .. 1 And now for the drum roll.. SCLN... 20 .. 0.2 (and I note that the present year P/S is about 12, and sales are growing at over 100%/year. I just used the yahoo figure of 20 to be consistent, since I got all the other data from yahoo profiles) Sciclone is under-priced. I doubt it will stay that way for long in this biotech hungry market.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next